Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Alaaldin M Alkilany
 -- 2358 2023-07-23 23:13:01 |
2 format correct
Conner Chen
-18 word(s) 2340 2023-07-24 07:52:40 | |
3 format correct
Conner Chen
Meta information modification 2340 2023-07-26 03:53:47 | |
4 format correct
Conner Chen
Meta information modification 2340 2023-07-26 03:55:12 |

Video Upload Options

Do you have a full video?
Send video materials Upload full video

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Idoudi, S.; Ismail, R.; Rachid, O.; Elhissi, A.; Alkilany, A.M. AuNP-liposome Nanocomposites: Architectures, Chemistry of Preparation, Analytical Characterization. Encyclopedia. Available online: https://encyclopedia.pub/entry/47149 (accessed on 27 July 2024).
Idoudi S, Ismail R, Rachid O, Elhissi A, Alkilany AM. AuNP-liposome Nanocomposites: Architectures, Chemistry of Preparation, Analytical Characterization. Encyclopedia. Available at: https://encyclopedia.pub/entry/47149. Accessed July 27, 2024.
Idoudi, Sourour, Roua Ismail, Ousama Rachid, Abdelbary Elhissi, Alaaldin M Alkilany. "AuNP-liposome Nanocomposites: Architectures, Chemistry of Preparation, Analytical Characterization" Encyclopedia, https://encyclopedia.pub/entry/47149 (accessed July 27, 2024).
Idoudi, S., Ismail, R., Rachid, O., Elhissi, A., & Alkilany, A.M. (2023, July 23). AuNP-liposome Nanocomposites: Architectures, Chemistry of Preparation, Analytical Characterization. In Encyclopedia. https://encyclopedia.pub/entry/47149
Idoudi, Sourour, et al. "AuNP-liposome Nanocomposites: Architectures, Chemistry of Preparation, Analytical Characterization." Encyclopedia. Web. 23 July, 2023.
AuNP-liposome Nanocomposites: Architectures, Chemistry of Preparation, Analytical Characterization
Edit
This entry is adapted from the peer-reviewed paper 10.3390/jnt4030010

These contents aim to provide a comprehensive understanding of the various architectures of AuNP-liposome nanocomposites and the factors influencing their formation. The objectives of these contents are to: 1. Define the term "architecture" concerning the spatial assembly of AuNP (gold nanoparticles) and liposomes, highlighting the various forms in which these assemblies can exist. 2. Explain how the architectures of AuNP-liposome nanocomposites depend on factors such as the size, shape, and surface chemistry of AuNP, as well as the characteristics of the hosting liposomes and the methods used to prepare the nanocomposites. 4. Discuss the different starting materials that can be used to create AuNP-liposome nanocomposites, including pre-prepared AuNP, gold ions that need to be reduced in situ, and ionic/molecular precursors of gold. 4. Describe the specific chemistry which can be employed to encapsulate hydrophilic and hydrophobic pre-prepared AuNP into liposomes, depending on the type of interactions (electrostatic or covalent) provided and the size of the AuNP.

gold nanoparticles plasmonic liposomes lipid

1. Unveiling the Architectures of AuNP-Liposome Nanocomposites

The term “architecture” herein as the spatial assembly of AuNP and liposomes, which can take various forms: AuNP in the aqueous core of the liposome, AuNP on the outermost shell of the liposome, AuNP in the bilayer or even mixed assemblies. These architectures depend on the size, shape and surface chemistry of AuNP as well as the hosting liposomes and the employed chemistries/methods to prepare the nanocomposites. The starting materials for AuNP in the AuNP-liposome nanocomposites can be either pre-prepared AuNP or gold ions that need to be reduced in-situ. Hydrophilic pre-prepared AuNP can be assembled on the outermost layer of the liposomes (Figure 1A) if enough attractions (electrostatic or covalent) are provided [1]. If a suspension of the Hydrophilic pre-prepared AuNP was used as the hydration media to prepare the liposomes, AuNP can be encapsulated into the aqueous core as demonstrated in Figure 1B [2]. Alternatively to using pre-prepared hydrophilic AuNP, ionic or molecular precursors of gold can be used as a starting material followed by the successful encapsulation of these precursor into the aqueous cores of liposomes and ultimately the reduction into AuNP [3]. Hydrophobic pre-prepared AuNP can be incorporated into the bilayer membrane as shown in Figure 1C [4] for ultrasmall AuNP with a diameter approaching the lipid membrane thickness (about 3–5 nm) and capped with hydrophobic capping agent (i.e., alkanethiols) [4][5].
Jnt 04 00010 g002 550
Figure 1. Illustration of different architectures of AuNP-liposome nanocomposites. Pre-prepared hydrophilic AuNP on the outermost shell (A) or in the aqueous reservoir (B) of a liposome. In (C), pre-prepared ultrasmall hydrophobic AuNP are embedded in the bilayer of a liposome. Figure created in BioRender.com.

2. Chemistries to Prepare AuNP-Liposome Nanocomposite

Typical formation of liposomes via thin film hydration method is shown in Figure 2 [6]. Briefly, the thin film hydration method implies the dissolution of lipids in a volatile organic solvent, followed by rotary evaporation of the solvent to form dried lipid film. Further, the lipid film swells by hydration in an aqueous medium and multilamellar vesicle starts to form. To obtain, uniform unilamellar vesicles, the suspension is passed through a polycarbonate filter with defined pore size [7]. AuNP can be introduced at different stages. Figure 2A, shows the introduction of pre-prepared hydrophilic AuNP as an aqueous suspension to hydrate the dried lipid film, which results in the encapsulation of AuNP into the aqueous core of the formed liposomes. Figure 2B, shows the introduction of AuNP at much later stage, where the liposome is already formed and thus the resulting architecture will be mostly assembled AuNP on the liposome outer shell (i.e., covalent or electrostatic binding). Chemistries described in Figure 2 requires hydrophilic AuNP with size typically smaller than the size of the liposome and typically results in poor encapsulation yield [3]. After the formation of AuNP-liposome nanocomposite, unencapsulated AuNPs could be removed using several purification methods including repeated slow-speed centrifugation or density-based fractionation [8][9][10].
Jnt 04 00010 g003 550
Figure 2. Schematic illustration of the preparation of AuNP-liposome nanocomposite using hydrophilic AuNP. Note that the preparations of two different architectures are sketched: AuNP in the aqueous core of the liposomes (A) and AuNP on the outermost shell of the liposome (B). For the later, attractive forces (electrostatic or covalent interaction) should exist for stable assembly. Figure created in BioRender.com.
For hydrophobic AuNP with small size (i.e., alkanethiol-capped AuNP with diameter less than 5 nm), AuNP can be introduced in the first step and suspended in the organic solvent with the dissolved phospholipid as shown in Figure 3. Upon drying, phospholipid and hydrophobic AuNP will form a dried film, which upon hydration will result in liposome that encapsulate the small AuNP in the bilayer membrane [4]. It is worth to mention that this protocol can only be applied for small AuNP that individually do not exhibit optical properties in the Vis-NIR [11][12]. Moreover, the incorporation of AuNP in the bilayer may result in significant impact on the stability of the hosting liposome and fragmentation into micelles [3]. Furthermore, the fundamental drawback of this technique is that it possesses low encapsulation efficiency, which necessitates an extra step for removing the free AuNP [13]. In addition, drug incorporation after liposomal preparation was correlated with higher encapsulation efficiency compared to drug incorporation during the liposomal formation, which guarantees improved drug bioavailability in the targeted site of action [14]. It is noteworthy to mention that the choice of the material incorporation (i.e., either after or during liposomal formation) depends on several standards, including the properties of the incorporated material (i.e., hydrophilic or lipophilic), the targeted profile of the drug release, and therapeutic applications of the prepared liposome-based nanocomposite [15][16][17][18][19]. Although production methods of liposome-based nanocomposites received significant efforts for scaling-up these fabrication techniques, some concerns include the poor colloidal stability profile, low encapsulation efficiencies, toxicity coming from the organic solvents used during synthesis process, and high costs of large-scale fabrication are associated with the production of liposome-based nanocomposites [14]. However, these limitations are variable based on the production techniques followed during the liposomal formation process. In other words, some liposome production methods (i.e., Freeze Drying, Reverse-Phase Evaporation, and Membrane Contactor) are among the useful techniques that are efficient for large-scale fabrication of liposome-based nanocomposites.
Jnt 04 00010 g004 550
Figure 3. Schematic illustration of the preparation of AuNP-liposome nanocomposite using ultra-small hydrophobic AuNP. Note that the resulting architectures implies the incorporation of AuNP into the lipid membrane bilayer. Figure created in BioRender.com.
Alternatively, liposomal dried film can be rehydrated with a reducing agent and then gold ions can be introduced and selectively reduced inside the aqueous core of the liposomes as shown in Figure 4A, which could be called in-liposome reduction approach [3]. Lee et. al. utilized this approach with sodium citrate or ascorbic acid as reducing agents and tetrachloroaurate ions as the gold precursors, while the reduction was carried out at room temperature overnight. Employing the in-liposome reduction approach, the research group prepared seven types of AuNP-liposome nanocomposites with tunable size, metal compositions and optical properties [3]. On-liposome reduction approach is another pathway where gold undergoes reduction on the surface of pre-synthesized liposomes (Figure 4B) [20]. Table 1 summarizes the reported chemistries used to prepare AuNP-liposome nanocomposites and the physiochemical properties of each component and the resulting products.
Jnt 04 00010 g005 550
Figure 4. Schematic illustration of the AuNP-liposome nanocomposites formation using the “in-liposome” (A) and “on-liposome” (B) reduction approaches. Figure created in BioRender.com.
In the preparation of AuNR, shape-directing agents (i.e., CTAB) are used to promote the anisotropic growth of AuNR. Unfortunately CTAB has cytotoxic profile which limits the biomedical applications of CTAB-capped AuNR [21][22][23]. In this regard, Gudlur et al. reported the CTAB-free preparation of AuNR using cationic liposomes as a substituent for the CTAB in order to improve the biocompatibility of AuNR [24]. The authors used cationic pre-prepared liposomes that were mixed with gold precursor (HAuCl4) in the presence of silver salt, reducing agent (ascorbic acid), and followed by heating at 40 °C to prepare anisotropic AuNR-liposome nanocomposite. Interestingly, AuNR-liposome nanocomposite potentially induced a significant photothermal ability by hyperthermia-induced cell death in different cancer cell lines, and thus resulting in enhanced cellular uptake compared to CTAB-mediated AuNR. However, the actual role of liposomes in the synthesis process of AuNR is still unknown, and much research needs to be conducted to validate this emerging method.
Table 1. Examples of reported AuNP-liposome nanocomposites.
AuNP Characteristics Nanocomposite Preparation Chemistry Nanocomposite Characteristics Outcomes and Remarks References
  • Sodium citrate or ascorbic acid as reducing agents
  • Liposomes encoded with the reducing agent were resuspended in the gold precursor to form AuNP-liposome by electrostatic attraction
  • Size of 28–161 nm
  • Spherical shape
  • Enhanced colloidal stability
  • Selective encapsulation of reducing agent in to liposomes allows self-crystallization of AuNP within the liposome
 [3]
  • 10–50 nm with
  • Glycerol as a reducing agent
  • Stable AuNP for two months without an added stabilizer
  • AuNP were covalently immobilized on the thiol-functionalized surface of the liposome prepared by thin film hydration method
  • Size of 190 nm
  • Spherical shape
  • The percentage of glycerol has no influence on the size and the polydispersity index
  • Possible immuno-sensing applications
 [1]
  • 25 nm PEGylated using Polyethylene glycol
  • Zeta potential of −29.6 mV
  • Cationic liposomes prepared by thin-layer evaporation method were decorated using anionic PEGylated AuNP using electrostatic interactions
  • Size of 180–389 nm
  • Zeta potential of 43–51 mV
  • Potential biomedical applications related to drug delivery
 [25]
  • 6 nm capped with Cetyltrimethylammonium bromide (CTAB)
  • Negatively charged liposomes prepared by thin film hydration method were electrostatically bound to the positive AuNP
  • Size of 177.3 nm
  • Zeta potential of 4.4 mV
  • 87.44% loading capacity of doxorubicin inside the AuNP-liposome nanocomposites
  • Possible application for cancer therapy
 [26]
  • 19 nm capped with procyanidin
  • Negatively charged AuNPs were electrostatically bound to the positively charged liposomes prepared by thin film hydration method
  • Size of 200–350 nm
  • zeta potential of –26.01 mV
  • Spherical shape
  • Stable profile after AuNP incorporation
  • Excellent light–controlled drug release
  • Combination between Doxorubicin-loaded AuNP-liposome nanocomposites and laser irradiation
  • supports their medical application for cancer therapy
 [27]
  • Sodium citrate as a reducing agent
  • Functionalized with carboxyl groups and silver
  • Negative AuNP were covalently linked (using EDC and NHS) * to the positive amino-modified liposomes surfaces prepared by thin film hydration method
  • Size of 215.5 nm
  • Zeta potential of −11.6 mV
  • 90% encapsulation of Doxorubicin with increased drug release under laser stimulation
  • Potential biomedical applications related to cancer therapy
 [28]
  • 14.1 nm coated with Citrate
  • Negative AuNP were electrostatically adsorbed onto the zwitterionic liposome surface by the gel-liquid phase transition of the lipid membrane
  • Size of 105 nm
  • Stable size over 1 week of incubation at room temperature
  • Spherical morphology
  • Protecting agents possess a key factor on linear self-assembly of AuNP within the liposome surface
 [29]
  • Size of 2−8 nm with ascorbic acid as a reducing agent
  • In situ reduction of AuNP on the liposome surface
  • Size of 100−120 nm
  • Spherical shape
  • Biodistribution studies confirm no cytotoxic profile of the AuNP-liposome nanocomposites
 [20]
  • Size of 20–40 nm with sodium citrate as a reducing agent
  • AuNP were noncovalently encapsulated inside liposomes prepared by thin film hydration method
  • Size of 60–80 nm
  • Spherical shape
  • Zeta potential of −10.4 mV
  • Induction of time and dose dependent death of breast cancer cells
 [30]
  • Ascorbic acid as a reducing agent
  • In situ reduction of positive AuNP on the negative liposome surface prepared by thin film hydration method
  • Size of 100–150 nm
  • Spherical shape
  • Zeta potential of 20 mV
  • Potential biomedical applications for acne treatment
 [31]
* EDC: 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide; NHS: N-hydroxysuccinimide.

3. Analytical Characterization of AuNP-Liposome Nanocomposites

Transmission electron microscopy (TEM) is a typical tool to visualize the architecture of AuNP-liposome nanocomposites and confirm the spatial distribution of AuNP whether on the outermost shell of the liposome, inside the aqueous core, or within the liposome bilayer. However, negative staining is usually required, and thus staining-related artifacts are possible challenge. Another challenge is related to the two-dimensional nature of the TEM imaging, which makes it difficult to confirm if the nanoparticles are “on” or “in” the liposome. A more complex tool is the Cryogenic transmission electron microscopy (Cryo-TEM), where thin film of liposome suspension is frozen under liquid nitrogen temperature [32]. The resulting vitrified ice film is extremely thin and can be imaged directly by EM. Alternative indirect method is the use of the sodium cyanide test, in which the successful coating of the AuNP with lipids can be tested using the oxidation capacity of cyanide to the encapsulated AuNP and the protection role of the lipid bilayer [33]. In this assay, the lipidic shell that coats the AuNP surface acts as a non-ion-permeable barrier that protects the golden core from exposure to cyanide ions as shown in Figure 5. For encapsulated AuNP, addition of cyanide will prevent or delay the oxidation of the protected AuNP, and thus the original color of the suspension will be maintained compared to control naked AuNP [33]. If AuNP is “on” the liposome or simply suspended in the same media without effective encapsulation, then added cyanide can oxidize the AuNP and the suspension color will disappear. Moreover, brilliant color of nanogold and its unique plasmonic optical extinction in the Visible-NIR region of the spectrum can be followed to confirm the formation of AuNP-liposome nanocomposites [34]. Coloration of liposome is a visual evidence supporting the formation of AuNP-liposome nanocomposites. Elemental analysis using energy dispersive spectroscopy (EDS) can be employed to further support the formation of AuNP-liposome nanocomposites, looking for the gold fingerprints [35]. Quantitively, gold content can be measured using inductively coupled mass spectrometry (ICP-MS) and reported as weight percent of the nanocomposite [36]. The various analytical modalities that can be used to confirm the presence, quantify and visualize the encapsulated AuNP are justifications to use AuNP as labels for liposomes, and thus to understand the biological interactions and fate of labeled liposomes. It is noteworthy to highlight the need to compare information gathered by complementary techniques to confirm the properties of the prepared AuNP-liposome nanocomposites. For instance, morphological information obtained from SEM and TEM could be further correlated with the optical absorption spectra of the nanocomposite where coloration of liposomes and AuNP and its unique plasmonic optical extinction in the Visible-NIR region could confirm the formation of the AuNP-liposome nanocomposites and its size that correlates with unique wavelengths [20][34][37]. Moreover, correlating the data obtained by FTIR, XPS, and ICP-MS could provide insights on the overall structure, composition, and surface properties of the AuNP-liposome nanocomposites [35][38].
Jnt 04 00010 g007 550
Figure 6. Graphical illustration of the protective properties of the AuNP encapsulated into the liposomal core against chemical etching with cyanide ions. Figure created in BioRender.com.

References

  1. Barroso, M.F.; Luna, M.A.; Tabares, J.S.F.; Delerue-Matos, C.; Correa, N.M.; Moyano, F.; Molina, P.G. Gold nanoparticles covalently assembled onto vesicle structures as possible biosensing platform. Beilstein J. Nanotechnol. 2016, 7, 655–663.
  2. Paasonen, L.; Sipilä, T.; Subrizi, A.; Laurinmäki, P.; Butcher, S.J.; Rappolt, M.; Yaghmur, A.; Urtti, A.; Yliperttula, M. Gold-embedded photosensitive liposomes for drug delivery: Triggering mechanism and intracellular release. J. Control Release 2010, 147, 136–143.
  3. Lee, J.-H.; Shin, Y.; Lee, W.; Whang, K.; Kim, D.; Lee, L.P.; Choi, J.-W.; Kang, T. General and programmable synthesis of hybrid liposome/metal nanoparticles. Sci. Adv. 2016, 2, e1601838.
  4. Park, S.-H.; Oh, S.-G.; Mun, J.-Y.; Han, S.-S. Loading of gold nanoparticles inside the DPPC bilayers of liposome and their effects on membrane fluidities. Colloids Surf. B Biointerfaces 2006, 48, 112–118.
  5. Regan, D.; Williams, J.B.; Borri, P.; Langbein, W. Lipid Bilayer Thickness Measured by Quantitative DIC Reveals Phase Transitions and Effects of Substrate Hydrophilicity. Langmuir 2019, 35, 13805–13814.
  6. Szoka, F.; Papahadjopoulos, D. Comparative Properties and Methods of Preparation of Lipid Vesicles (Liposomes). Annu. Rev. Biophys. Bioeng. 1980, 9, 467–508.
  7. Olson, F.; Hunt, C.; Szoka, F.; Vail, W.; Papahadjopoulos, D. Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim. Biophys. Acta (BBA)—Biomembr. 1979, 557, 9–23.
  8. Veeren, A.; Ogunyankin, M.O.; Shin, J.E.; Zasadzinski, J.A. Liposome-Tethered Gold Nanoparticles Triggered by Pulsed NIR Light for Rapid Liposome Contents Release and Endosome Escape. Pharmaceutics 2022, 14, 701.
  9. Kojima, C.; Hirano, Y.; Yuba, E.; Harada, A.; Kono, K. Preparation and characterization of complexes of liposomes with gold nanoparticles. Colloids Surf. B Biointerfaces 2008, 66, 246–252.
  10. Sánchez-López, V.; Fernández-Romero, J.; Gómez-Hens, A. Evaluation of liposome populations using a sucrose density gradient centrifugation approach coupled to a continuous flow system. Anal. Chim. Acta 2009, 645, 79–85.
  11. Lee, H.-Y.; Shin, S.H.R.; Abezgauz, L.L.; Lewis, S.A.; Chirsan, A.M.; Danino, D.D.; Bishop, K.J.M. Integration of Gold Nanoparticles into Bilayer Structures via Adaptive Surface Chemistry. J. Am. Chem. Soc. 2013, 135, 5950–5953.
  12. Von White, I.G.; Chen, Y.; Roder-Hanna, J.; Bothun, G.D.; Kitchens, C.L. Structural and Thermal Analysis of Lipid Vesicles Encapsulating Hydrophobic Gold Nanoparticles. ACS Nano 2012, 6, 4678–4685.
  13. Liu, P.; Chen, G.; Zhang, J. A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives. Molecules 2022, 27, 1372.
  14. Lombardo, D.; Kiselev, M.A. Methods of Liposomes Preparation: Formation and Control Factors of Versatile Nanocarriers for Biomedical and Nanomedicine Application. Pharmaceutics 2022, 14, 543.
  15. Nsairat, H.; Khater, D.; Sayed, U.; Odeh, F.; Al Bawab, A.; Alshaer, W. Liposomes: Structure, composition, types, and clinical applications. Heliyon 2022, 8, e09394.
  16. De Piano, R.; Caccavo, D.; Lamberti, G.; Remaut, K.; Seynaeve, H.; Barba, A.A. A New Productive Approach and Formulative Optimization for Curcumin Nanoliposomal Delivery Systems. Pharmaceutics 2023, 15, 959.
  17. Sudhakar, K.; Fuloria, S.; Subramaniyan, V.; Sathasivam, K.V.; Azad, A.K.; Swain, S.S.; Sekar, M.; Karupiah, S.; Porwal, O.; Sahoo, A.; et al. Ultraflexible Liposome Nanocargo as a Dermal and Transdermal Drug Delivery System. Nanomaterials 2021, 11, 2557.
  18. Sztandera, K.; Gorzkiewicz, M.; Klajnert-Maculewicz, B. Gold Nanoparticles in Cancer Treatment. Mol. Pharm. 2019, 16, 1–23.
  19. Sonkar, R.; Sonali; Jha, A.; Viswanadh, M.K.; Burande, A.S.; Narendra; Pawde, D.M.; Patel, K.K.; Singh, M.; Koch, B.; et al. Gold liposomes for brain-targeted drug delivery: Formulation and brain distribution kinetics. Mater. Sci. Eng. C 2020, 120, 111652.
  20. Rengan, A.K.; Bukhari, A.B.; Pradhan, A.; Malhotra, R.; Banerjee, R.; Srivastava, R.; De, A. In Vivo Analysis of Biodegradable Liposome Gold Nanoparticles as Efficient Agents for Photothermal Therapy of Cancer. Nano Lett. 2015, 15, 842–848.
  21. Kohout, C.; Santi, C.; Polito, L. Anisotropic Gold Nanoparticles in Biomedical Applications. Int. J. Mol. Sci. 2018, 19, 3385.
  22. Alkilany, A.M.; Nagaria, P.K.; Hexel, C.R.; Shaw, T.J.; Murphy, C.J.; Wyatt, M.D. Cellular Uptake and Cytotoxicity of Gold Nanorods: Molecular Origin of Cytotoxicity and Surface Effects. Small 2009, 5, 701–708.
  23. Alkilany, A.; Shatanawi, A.; Kurtz, T.; Caldwell, R. Toxicity and Cellular Uptake of Gold Nanorods in Vascular Endothelium and Smooth Muscles of Isolated Rat Blood Vessel: Importance of Surface Modification. Small 2012, 8, 1270–1278.
  24. Gudlur, S.; Goyal, G.; Pradhan, A.; Ho, J.C.S.; Srivastava, R.; Liedberg, B. Cationic Liposomes Enable Shape Control in Surfactant-Free Synthesis of Biocompatible Gold Nanorods. Chem. Mater. 2021, 33, 4558–4567.
  25. Știufiuc, G.F.; Nițică, S.; Toma, V.; Iacoviță, C.; Zahn, D.; Tetean, R.; Burzo, E.; Lucaciu, C.M.; Știufiuc, R.I. Synergistical Use of Electrostatic and Hydrophobic Interactions for the Synthesis of a New Class of Multifunctional Nanohybrids: Plasmonic Magneto-Liposomes. Nanomaterials 2019, 9, 1623.
  26. Zarchi, A.A.K.; Amini, S.M.; Salimi, A.; Kharazi, S. Synthesis and characterisation of liposomal doxorubicin with loaded gold nanoparticles. IET Nanobiotechnol. 2018, 12, 846–849.
  27. Hou, K.; Bao, M.; Xin, C.; Wang, L.; Zhang, H.; Zhao, H.; Wang, Z. Green synthesis of gold nanoparticles coated doxorubicin liposomes using procyanidins for light–controlled drug release. Adv. Powder Technol. 2020, 31, 3640–3649.
  28. Zhu, D.; Wang, Z.; Zong, S.; Zhang, Y.; Chen, C.; Zhang, R.; Yun, B.; Cui, Y. Investigating the Intracellular Behaviors of Liposomal Nanohybrids via SERS: Insights into the Influence of Metal Nanoparticles. Theranostics 2018, 8, 941–954.
  29. Sugikawa, K.; Kadota, T.; Yasuhara, K.; Ikeda, A. Anisotropic Self-Assembly of Citrate-Coated Gold Nanoparticles on Fluidic Liposomes. Angew. Chem. Int. Ed. 2016, 55, 4059–4063.
  30. Kunjiappan, S.; Panneerselvam, T.; Somasundaram, B.; Arunachalam, S.; Sankaranarayanan, M.; Parasuraman, P. Preparation of liposomes encapsulated Epirubicin-gold nanoparticles for Tumor specific delivery and release. Biomed. Phys. Eng. Express 2018, 4, 045027.
  31. Alvi, S.B.; Rajalakshmi, P.S.; Jogdand, A.; Sanjay, A.Y.; Veeresh, B.; John, R.; Rengan, A.K. Iontophoresis mediated localized delivery of liposomal gold nanoparticles for photothermal and photodynamic therapy of acne. Biomater. Sci. 2021, 9, 1421–1430.
  32. Baxa, U. Imaging of Liposomes by Transmission Electron Microscopy. Charact. Nanoparticles Intend. Drug Deliv. 2017, 1682, 73–88.
  33. Sitaula, S.; Mackiewicz, M.R.; Reed, S.M. Gold nanoparticles become stable to cyanide etch when coated with hybrid lipid bilayers. Chem. Commun. 2008, 26, 3013–3015.
  34. Singh, S.P.; Alvi, S.B.; Pemmaraju, D.B.; Singh, A.D.; Manda, S.V.; Srivastava, R.; Rengan, A.K. NIR triggered liposome gold nanoparticles entrapping curcumin as in situ adjuvant for photothermal treatment of skin cancer. Int. J. Biol. Macromol. 2018, 110, 375–382.
  35. Goh, E.T.H.; Cheung, P.C.F.; Akira, S.; Centre, B.; Defense, H. Doxorubicin/gold nanoparticles coated with liposomes for chemo- photothermal synergetic antitumor therapy. Nanotechnology 2018, 29, 405101.
  36. Charest, G.; Tippayamontri, T.; Shi, M.; Wehbe, M.; Anantha, M.; Bally, M.; Sanche, L. Concomitant Chemoradiation Therapy with Gold Nanoparticles and Platinum Drugs Co-Encapsulated in Liposomes. Int. J. Mol. Sci. 2020, 21, 4848.
  37. Jhun, J.; Moon, J.; Ryu, J.; Shin, Y.; Lee, S.; Cho, K.-H.; Kang, T.; Cho, M.-L.; Park, S.-H. Liposome/gold hybrid nanoparticle encoded with CoQ10 (LGNP-CoQ10) suppressed rheumatoid arthritis via STAT3/Th17 targeting. PLoS ONE 2020, 15, e0241080.
  38. Hachenberger, Y.U.; Rosenkranz, D.; Kriegel, F.L.; Krause, B.; Matschaß, R.; Reichardt, P.; Tentschert, J.; Laux, P.; Jakubowski, N.; Panne, U.; et al. Tackling Complex Analytical Tasks: An ISO/TS-Based Validation Approach for Hydrodynamic Chromatography Single Particle Inductively Coupled Plasma Mass Spectrometry. Materials 2020, 13, 1447.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Nanoscience & Nanotechnology
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Sourour Idoudi
,
Roua Ismail
,
Ousama Rachid
,
Abdelbary Elhissi
,
Alaaldin M Alkilany
View Times: 336
Revisions: 4 times (View History)
Update Date: 26 Jul 2023
Table of Contents
    1000/1000
    Hot Most Recent
    Video Production Service
    Feedback